Hong Kong’s Biotech IPO Craze Continues as Ascentage Soars 57%

(Bloomberg) -- Ascentage Pharma Group International went from Hong Kong’s hottest initial public offering this year to a huge debut as investors continue to embrace unproven Chinese health-care com...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.